Vesicle trafficking in cancer

Por Yarden, Yosef., Tarcic, Gabi.
Publicado em 2013

p38 MAP kinase mediates stress-induced internalization of EGFR: implications for cancer chemotherapy

Por Zwang, Yaara, Yarden, Yosef
Publicado em 2006

Regulation of signalling by microRNAs

Por Avraham, Roi, Yarden, Yosef
Publicado em 2012

Endocytosis and Cancer

Por Mellman, Ira, Yarden, Yosef
Publicado em 2013

Structure and function of epigen, the last EGFR ligand

Por Schneider, Marlon R., Yarden, Yosef
Publicado em 2013

Steering tumor progression through the transcriptional response to growth factors and stroma

Por Feldman, Morris E., Yarden, Yosef
Publicado em 2014

The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors

Por Schneider, Marlon R., Yarden, Yosef
Publicado no Oncogene (2015)

Src promotes destruction of c-Cbl: Implications for oncogenic synergy between Src and growth factor receptors

Por Bao, Jing, Gur, Gal, Yarden, Yosef
Publicado em 2003

Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy

Por Amit, Ido, Wides, Ron, Yarden, Yosef
Publicado em 2007

Regulation of MAPKs by growth factors and receptor tyrosine kinases

Por Katz, Menachem, Amit, Ido, Yarden, Yosef
Publicado em 2007

Roles for Growth Factors in Cancer Progression

Por Witsch, Esther, Sela, Michael, Yarden, Yosef
Publicado em 2010

The Consistency Test of the Cell Cycle: Roles for p53 and EGR1

Por Zwang, Yaara, Oren, Moshe, Yarden, Yosef
Publicado em 2012

Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3

Por Gaborit, Nadège, Lindzen, Moshit, Yarden, Yosef
Publicado no Hum Vaccin Immunother (2015)

Oncogenic mutant forms of EGFR: lessons in signal transduction and targets for cancer therapy

Por Pines, Gur, Köstler, Wolfgang J., Yarden, Yosef
Publicado em 2010

Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer

Por Emde, Anna, Köstler, Wolfgang J., Yarden, Yosef
Publicado em 2010

ERK-ERF-EGR1, a novel switch underlying acquisition of a motile phenotype

Por Ben-Chetrit, Nir, Tarcic, Gabi, Yarden, Yosef
Publicado em 2013

MicroRNAs and Growth Factors: An Alliance Propelling Tumor Progression

Por Kedmi, Merav, Sas-Chen, Aldema, Yarden, Yosef
Publicado no J Clin Med (2015)

Neu Differentiation Factor Stimulates Phosphorylation and Activation of the Sp1 Transcription Factor

Por Alroy, Iris, Soussan, Lior, Seger, Rony, Yarden, Yosef
Publicado em 1999

Tailored cancer immunotherapy using combinations of chemotherapy and a mixture of antibodies against EGF-receptor ligands

Por Lindzen, Moshit, Lavi, Sara, Leitner, Orith, Yarden, Yosef
Publicado em 2010

Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti‐cancer antibodies: IUPHAR Review 18

Por Carvalho, Silvia, Levi‐Schaffer, Francesca, Sela, Michael, Yarden, Yosef
Publicado no Br J Pharmacol (2016)